Linked Life Data

20739747

Source:http://linkedlifedata.com/resource/pubmed/id/20739747

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-9-2
pubmed:abstractText
The discovery several years ago that fibroblasts and other somatic cells from mice and humans can be reprogrammed to become inducible pluripotent stem (iPS) cells has created enthusiasm for their potential applications in regenerative medicine and for modeling human diseases. Two independent studies in this issue of the JCI provide evidence that iPS cells represent a promising source of hepatocytes for a wide range of applications, including cell transplantation, drug toxicity testing, patient-specific disease modeling, and even ex vivo gene therapy. But how far have we come?
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1558-8238
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3102-5
pubmed:dateRevised
2011-3-28
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
From skin cells to hepatocytes: advances in application of iPS cell technology.
pubmed:affiliation
Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania 19107, USA. Linda.greenbaum@jefferson.edu
pubmed:publicationType
Journal Article, Comment, Review, Research Support, N.I.H., Extramural